Assessing the Mutational Spectrum and Prevalence of Breast Cancer Risk Genes in an Unselected Hispanic Breast Cancer Cohort Using Population Genetic and Genomic Approaches

Assessing the Mutational Spectrum and Prevalence of Breast Cancer Risk Genes in an Unselected Hispanic Breast Cancer Cohort Using Population Genetic and Genomic Approaches

Author: Anna Marie de Asis Tuazon

Publisher:

Published: 2017

Total Pages:

ISBN-13: 9781369795776

DOWNLOAD EBOOK

Breast cancer is the leading cause of cancer incidence and mortality among Hispanic women. The research described here aimed to assess the mutation prevalence in three breast cancer genes (BRCA1, BRCA2 and PALB2) in unselected Hispanic breast cancer cases. Unselected cases with invasive breast cancer, recruited through a multi-center study in Colombia, were screened for BRCA1/2 and PALB2 mutations using genotyping and Illumina sequencing. Analyses focused on mutation prevalence and clinical characteristics of the mutation carriers. We identified 67 cases with a pathogenic or likely-pathogenic mutation in BRCA1 (n=42), BRCA2 (n=18), and PALB2 (n=7). Eighty-eight percent of these mutations were founder mutations. Remarkably, we found that 10.4% of the cohort, regardless of family history of cancer, carried a pathogenic mutation. The high mutation prevalence in this cohort, and the lack of family history in >60% of the mutation carriers, suggests that population-based genetic analysis can identify most Hispanic carriers who would otherwise be ineligible for testing. Additionally, among the high prevalence of founder mutations was the BRCA1 c.3331_3334delCAAG mutation. This particular mutation has been reported previously in other parts of the world. Mutation carriers from Colombia, Spain, Portugal, Brazil, Chile, and Angola, were subjected to haplotype analysis. Significantly, mutation carriers from these diverse countries share a common core haplotype, likely originating from Iberia (Spain and Portugal). The estimated age of the mutation in Colombia and Spain was consistent with the European colonization, and this story illustrates trans-continental immigration of an important breast cancer-associated mutation, highlighting the significance of studying diverse populations.


Hereditary Breast Cancer

Hereditary Breast Cancer

Author: Claudine Isaacs

Publisher: CRC Press

Published: 2007-09-19

Total Pages: 402

ISBN-13: 1420020366

DOWNLOAD EBOOK

Intended for medical oncologists, surgeons, obstetricians, gynecologists, geneticists, genetic counselors, and primary care physicians, this text presents the epidemiological, biological, and clinical issues associated with hereditary breast cancer. It offers clear guidance on the application and utilization of cancer risk assessment models, geneti


Molecular Epidemiology

Molecular Epidemiology

Author: Paul A. Schulte

Publisher: Academic Press

Published: 2012-12-02

Total Pages: 609

ISBN-13: 0323138578

DOWNLOAD EBOOK

This book will serve as a primer for both laboratory and field scientists who are shaping the emerging field of molecular epidemiology. Molecular epidemiology utilizes the same paradigm as traditional epidemiology but uses biological markers to identify exposure, disease or susceptibility. Schulte and Perera present the epidemiologic methods pertinent to biological markers. The book is also designed to enumerate the considerations necessary for valid field research and provide a resource on the salient and subtle features of biological indicators.


Systematic Reviews

Systematic Reviews

Author:

Publisher:

Published: 2009

Total Pages: 281

ISBN-13: 9781900640473

DOWNLOAD EBOOK

For adults. There is a pressing need for methodologically sound RCTs to confirm whether such interventions are helpful and, if so, for whom.


Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition

Accomplishments, Collaborative Projects and Future Initiatives in Breast Cancer Genetic Predisposition

Author: Paolo Peterlongo

Publisher: Frontiers Media SA

Published: 2019-10-16

Total Pages: 141

ISBN-13: 288963132X

DOWNLOAD EBOOK

In this eBook, we described the accomplishments, collaborative projects and future initiatives in the field of breast cancer genetic predisposition. More specifically, the articles included focused on aspects such as mutation screening in unexplored populations, identification and characterization of novel predisposing genes and mutations, and population screening.


How Tobacco Smoke Causes Disease

How Tobacco Smoke Causes Disease

Author: United States. Public Health Service. Office of the Surgeon General

Publisher:

Published: 2010

Total Pages: 728

ISBN-13:

DOWNLOAD EBOOK

This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.


Understanding Breast Cancer Genetics

Understanding Breast Cancer Genetics

Author: Barbara T. Zimmerman

Publisher: Univ. Press of Mississippi

Published: 2004

Total Pages: 142

ISBN-13: 9781578065783

DOWNLOAD EBOOK

Health & Sickness -- Consumer Health This book by a scientist whose background is in cellular and molecular biology examines the fearsome disease that strikes one in eight women in the United States. Although women are more likely to die of heart disease or of lung cancer, a diagnosis of breast cancer is the medical pronouncement that a woman is most likely to fear. It kills more than 40,000 Americans annually. Why are some women more vulnerable than others? The interplay between genetics and environment is suspected. Thus this book for general readers will help them understand the genetic bases of both sporadic and inherited breast cancers. Although only five to ten percent of breast cancer patients have inherited mutations in these genes, all women need to understand the genetic implications of the disease. In clear, concise language Barbara T. Zimmerman guides the reader through the complexities, discussing in detail the genes that are known to increase susceptibility and the ways they are passed on. Examining the general biology of breast cancer, Zimmerman describes how sporadic and inherited forms of the disease arise and how the location of the tumors can affect the body. She discusses genetic mutations and their roles in the development of tumors and tells how these potentially cancer-inducing genes were discovered. Covered too are the issues of risk, prevention, screening, diagnosis, therapy, and genetic testing and counseling. Zimmerman concludes with a comprehensive analysis of current research and with an emphasis on how a woman's understanding of inherited breast cancer can help doctors seeking to design better methods for prevention and therapy. A useful list of resources for further information about the genetic causes of breast cancer is included. Barbara T. Zimmerman did her graduate work in experimental pathology and her post-doctoral research in the cellular and molecular processes of disease. Widely published, she is the manager of the Denver-based firm Biomedical Communication and Consulting.


Breast Cancer Metastasis and Drug Resistance

Breast Cancer Metastasis and Drug Resistance

Author: Aamir Ahmad

Publisher: Springer Nature

Published: 2019-08-27

Total Pages: 427

ISBN-13: 3030203018

DOWNLOAD EBOOK

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.


Diagnosis and Management of Ovarian Disorders

Diagnosis and Management of Ovarian Disorders

Author: Albert Altchek

Publisher: Elsevier

Published: 2003-09-04

Total Pages: 595

ISBN-13: 008049451X

DOWNLOAD EBOOK

This updated second edition of Diagnosis and Management of Ovarian Disorders provides thorough, yet succinct insight into the ever-changing realm of ovarian disorders. It presents a novel multidisciplinary approach to the subject as described by clinicians, surgeons, pathologists, basic scientists and related medical researchers. Topics covered include reproductive technology, early diagnosis of ovarian cancer, and management of menopause among others. The breadth of information provided by this book will appeal to clinicians and researchers involved in the study and treatment of ovarian disorders. KEY FEATURES* Includes updated information on early diagnosis of ovarian cancer* Reviews new diagnostic techniques for ovarian disorders* Discusses latest information on reproductive technology* Presents translational treatment linking laboratory research with clinical medicine